State Street Corp Lucid Diagnostics Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, State Street Corp holds 623,068 shares of LUCD stock, worth $623,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
623,068
Previous 44,981
1285.18%
Holding current value
$623,068
Previous $67,000
968.66%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LUCD
# of Institutions
69Shares Held
15.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.13MShares$4.13 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA2.73MShares$2.73 Million0.13% of portfolio
-
Geode Capital Management, LLC Boston, MA1.58MShares$1.58 Million0.0% of portfolio
-
Luminus Management LLC Houston, TX795KShares$794,8300.92% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL738KShares$738,2770.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $38.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...